Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT01776008
Brief Title: Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer

First Submitted : January 23, 2013
First Submitted that Met QC Criteria : January 23, 2013
First Posted : January 25, 2013 (Estimate)

Results First Submitted : September 7, 2017
Results First Submitted that Met QC Criteria : April 6, 2018
Results First Posted : May 8, 2018

Last Update Submitted that Met QC Criteria : April 6, 2018
Last Update Posted : May 8, 2018